Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience

Detalles Bibliográficos
Autores principales: Talreja, Vikas T., Noronha, Vanita, Joshi, Amit, Patil, Vijay, Mahajan, Abhishek, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852628/
https://www.ncbi.nlm.nih.gov/pubmed/31807477
http://dx.doi.org/10.4103/sajc.sajc_169_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852628/
https://www.ncbi.nlm.nih.gov/pubmed/31807477
http://dx.doi.org/10.4103/sajc.sajc_169_19

Ejemplares similares